Intrathecal Baclofen infusion. Effect on bladder management programs in patients with myelopathy

F. Frost, J. Nanninga, R. Penn, S. Savoy, Y. Wu

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Intrathecal administration of Baclofen, a GABA agonist, through an implantable drug delivery pump has been demonstrated to be effective in the treatment of limb spasticity in patients with myelopathy. Three patients, followed before and after pump placement, experienced satisfactory spasticity relief and improvement in areas of self-care and mobility. Improvement in the bladder management programs of each patient was noted. These changes coincided with improvement on urodynamic studies, defined as either an increase in bladder capacity or a decrease in sphincter dyssynergia. Changes in bladder function were associated with the initiation of intrathecal therapy and with changes in pump-delivered dosages. In selected patients, intrathecal baclofen infusion can have a benficial effect on bladder management programs.

Original languageEnglish (US)
Pages (from-to)112-115
Number of pages4
JournalAmerican Journal of Physical Medicine and Rehabilitation
Issue number3
StatePublished - 1989

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation


Dive into the research topics of 'Intrathecal Baclofen infusion. Effect on bladder management programs in patients with myelopathy'. Together they form a unique fingerprint.

Cite this